Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2013

View Archived Issues

Ascendis Pharma discloses novel treprostinil prodrugs

CSIR prepares new agents for tuberculosis

Scientists at the Universite Laval divulge novel anticancer agents

Cellceutix initiates agreement to acquire a new compound

BioTime and LifeMap Sciences enter into data mining collaboration

Starpharma reports animal data for dendrimer-based formulation of doxorubicin

Advanced Cell Diagnostics and Johns Hopkins sign agreement for cancer immunotherapy

Roche synthesizes new BTK inhibitors

Roche presents novel tyrosine-protein kinase inhibitors

Potent efficacy for faldaprevir demonstrated in the STARTverso 4 trial

Brodalumab demonstrates efficacy in patients with psoriasis

OPKO Health completes acquisition

Discgenics' injectable disc-derived stem cell therapy shows promising results in animals

FDA advisory committee votes against approval of Depomed's Sefelsa

Silence Therapeutics gains clearance for phase Ib/IIa trial of ATU-027 in pancreatic cancer

Application for additional indication of Glivec withdrawn in Japan

Phase I/II trial of DCVax-Direct to begin within next 60 days

Rbm5 proves essential for the progression of spermatogenesis

Dicer1 gene linked to sperm maturation

Roche obtains E.U. approval for Perjeta

FcERI-mimetic peptide demonstrates protection from anaphylaxis in vivo

FDA issues second complete response letter for Xarelto

FDA committee votes on approval of low-dose mesylate salt of paroxetine

Radiotracer [64Cu]-TP-3805 distinguishes benign from breast cancer tissues

Galectin Therapeutics receives FDA clearance for trial of GR-MD-02

Merck Serono creates spin-off company focused on gastrointestinal disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026